25 XP   0   0   10

Hubei Guangji Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Hubei Guangji Pharmaceutical Co Ltd together

PenkeI guess you are interested in Hubei Guangji Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Hubei Guangji Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Hubei Guangji Pharmaceutical Co Ltd

I send you an email if I find something interesting about Hubei Guangji Pharmaceutical Co Ltd.

Quick analysis of Hubei Guangji Pharmaceutical Co Ltd (30 sec.)










What can you expect buying and holding a share of Hubei Guangji Pharmaceutical Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.06
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥4.21
Expected worth in 1 year
¥4.67
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
¥0.91
Return On Investment
17.2%

For what price can you sell your share?

Current Price per Share
¥5.32
Expected price per share
¥4.11 - ¥6.18
How sure are you?
50%

1. Valuation of Hubei Guangji Pharmaceutical Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥5.32

Intrinsic Value Per Share

¥-6.45 - ¥-0.43

Total Value Per Share

¥-2.24 - ¥3.78

2. Growth of Hubei Guangji Pharmaceutical Co Ltd (5 min.)




Is Hubei Guangji Pharmaceutical Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$206m$200.3m$5.6m2.7%

How much money is Hubei Guangji Pharmaceutical Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$6.9m$15.2m-$8.2m-118.6%
Net Profit Margin6.3%13.2%--

How much money comes from the company's main activities?

3. Financial Health of Hubei Guangji Pharmaceutical Co Ltd (5 min.)




What can you expect buying and holding a share of Hubei Guangji Pharmaceutical Co Ltd? (5 min.)

Welcome investor! Hubei Guangji Pharmaceutical Co Ltd's management wants to use your money to grow the business. In return you get a share of Hubei Guangji Pharmaceutical Co Ltd.

What can you expect buying and holding a share of Hubei Guangji Pharmaceutical Co Ltd?

First you should know what it really means to hold a share of Hubei Guangji Pharmaceutical Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Hubei Guangji Pharmaceutical Co Ltd is ¥5.32. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Hubei Guangji Pharmaceutical Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Hubei Guangji Pharmaceutical Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥4.21. Based on the TTM, the Book Value Change Per Share is ¥0.11 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.24 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.11 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Hubei Guangji Pharmaceutical Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.020.4%0.020.4%0.040.8%0.040.7%0.030.6%
Usd Book Value Change Per Share0.020.3%0.020.3%0.030.6%0.061.1%0.030.5%
Usd Dividend Per Share0.020.3%0.020.3%0.010.3%0.020.3%0.010.3%
Usd Total Gains Per Share0.030.6%0.030.6%0.050.9%0.071.4%0.040.8%
Usd Price Per Share1.06-1.06-1.08-1.08-1.41-
Price to Earnings Ratio53.83-53.83-25.16-32.76-143.73-
Price-to-Total Gains Ratio33.57-33.57-22.94-20.98-183.05-
Price to Book Ratio1.82-1.82-1.91-2.38-4.87-
Price-to-Total Gains Ratio33.57-33.57-22.94-20.98-183.05-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.734692
Number of shares1361
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share0.020.06
Usd Total Gains Per Share0.030.07
Gains per Quarter (1361 shares)42.8998.98
Gains per Year (1361 shares)171.57395.92
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1858616287309386
2171172334175617782
32562585062629261178
434234467835012341574
542743185043715431970
6513517102252418512366
7598603119461221602762
8684689136669924683158
9769775153878627773554
10855861171087430853950

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.01.090.0%21.00.02.091.3%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.02.00.080.0%18.05.00.078.3%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%23.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%19.04.00.082.6%

Fundamentals of Hubei Guangji Pharmaceutical Co Ltd

About Hubei Guangji Pharmaceutical Co Ltd

Hubei Guangji Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical raw materials, medicinal feed additives, fine chemicals, and preparations in China. The company also exports its products to approximately 30 countries and regions worldwide. Hubei Guangji Pharmaceutical Co., Ltd. was founded in 1969 and is based in Wuxue, China.

Fundamental data was last updated by Penke on 2024-04-14 11:19:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Hubei Guangji Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Hubei Guangji Pharmaceutical Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Hubei Guangji Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 6.3% means that ¥0.06 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Hubei Guangji Pharmaceutical Co Ltd:

  • The MRQ is 6.3%. The company is making a profit. +1
  • The TTM is 6.3%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ6.3%TTM6.3%0.0%
TTM6.3%YOY13.2%-6.8%
TTM6.3%5Y12.5%-6.2%
5Y12.5%10Y10.0%+2.5%
1.1.2. Return on Assets

Shows how efficient Hubei Guangji Pharmaceutical Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Hubei Guangji Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • 2.0% Return on Assets means that Hubei Guangji Pharmaceutical Co Ltd generated ¥0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Hubei Guangji Pharmaceutical Co Ltd:

  • The MRQ is 2.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ2.0%TTM2.0%0.0%
TTM2.0%YOY5.4%-3.3%
TTM2.0%5Y5.2%-3.2%
5Y5.2%10Y4.3%+1.0%
1.1.3. Return on Equity

Shows how efficient Hubei Guangji Pharmaceutical Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Hubei Guangji Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • 3.4% Return on Equity means Hubei Guangji Pharmaceutical Co Ltd generated ¥0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Hubei Guangji Pharmaceutical Co Ltd:

  • The MRQ is 3.4%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.4%TTM3.4%0.0%
TTM3.4%YOY7.5%-4.2%
TTM3.4%5Y9.0%-5.7%
5Y9.0%10Y8.5%+0.5%

1.2. Operating Efficiency of Hubei Guangji Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Hubei Guangji Pharmaceutical Co Ltd is operating .

  • Measures how much profit Hubei Guangji Pharmaceutical Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Hubei Guangji Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 6.4% means the company generated ¥0.06  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Hubei Guangji Pharmaceutical Co Ltd:

  • The MRQ is 6.4%. The company is operating less efficient.
  • The TTM is 6.4%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ6.4%TTM6.4%0.0%
TTM6.4%YOY10.4%-4.0%
TTM6.4%5Y14.0%-7.6%
5Y14.0%10Y15.1%-1.1%
1.2.2. Operating Ratio

Measures how efficient Hubei Guangji Pharmaceutical Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 1.52 means that the operating costs are ¥1.52 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Hubei Guangji Pharmaceutical Co Ltd:

  • The MRQ is 1.522. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.522. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.522TTM1.5220.000
TTM1.522YOY1.502+0.020
TTM1.5225Y1.389+0.133
5Y1.38910Y1.250+0.139

1.3. Liquidity of Hubei Guangji Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Hubei Guangji Pharmaceutical Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 1.54 means the company has ¥1.54 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Hubei Guangji Pharmaceutical Co Ltd:

  • The MRQ is 1.537. The company is able to pay all its short-term debts. +1
  • The TTM is 1.537. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.537TTM1.5370.000
TTM1.537YOY1.312+0.225
TTM1.5375Y1.150+0.387
5Y1.15010Y0.760+0.390
1.3.2. Quick Ratio

Measures if Hubei Guangji Pharmaceutical Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Hubei Guangji Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.31 means the company can pay off ¥0.31 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Hubei Guangji Pharmaceutical Co Ltd:

  • The MRQ is 0.309. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.309. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.309TTM0.3090.000
TTM0.309YOY0.376-0.068
TTM0.3095Y0.264+0.045
5Y0.26410Y0.225+0.039

1.4. Solvency of Hubei Guangji Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Hubei Guangji Pharmaceutical Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Hubei Guangji Pharmaceutical Co Ltd to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.40 means that Hubei Guangji Pharmaceutical Co Ltd assets are financed with 39.6% credit (debt) and the remaining percentage (100% - 39.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Hubei Guangji Pharmaceutical Co Ltd:

  • The MRQ is 0.396. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.396. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.396TTM0.3960.000
TTM0.396YOY0.292+0.104
TTM0.3965Y0.386+0.009
5Y0.38610Y0.495-0.109
1.4.2. Debt to Equity Ratio

Measures if Hubei Guangji Pharmaceutical Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Hubei Guangji Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 65.0% means that company has ¥0.65 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Hubei Guangji Pharmaceutical Co Ltd:

  • The MRQ is 0.650. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.650. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.650TTM0.6500.000
TTM0.650YOY0.409+0.241
TTM0.6505Y0.654-0.004
5Y0.65410Y1.138-0.484

2. Market Valuation of Hubei Guangji Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Hubei Guangji Pharmaceutical Co Ltd generates.

  • Above 15 is considered overpriced but always compare Hubei Guangji Pharmaceutical Co Ltd to the Drug Manufacturers - General industry mean.
  • A PE ratio of 53.83 means the investor is paying ¥53.83 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Hubei Guangji Pharmaceutical Co Ltd:

  • The EOD is 37.389. Based on the earnings, the company is overpriced. -1
  • The MRQ is 53.834. Based on the earnings, the company is expensive. -2
  • The TTM is 53.834. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD37.389MRQ53.834-16.446
MRQ53.834TTM53.8340.000
TTM53.834YOY25.164+28.671
TTM53.8345Y32.760+21.074
5Y32.76010Y143.726-110.966
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Hubei Guangji Pharmaceutical Co Ltd:

  • The EOD is -11.872. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -17.093. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -17.093. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-11.872MRQ-17.093+5.222
MRQ-17.093TTM-17.0930.000
TTM-17.093YOY-133.858+116.764
TTM-17.0935Y21.191-38.284
5Y21.19110Y25.575-4.384
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Hubei Guangji Pharmaceutical Co Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 1.82 means the investor is paying ¥1.82 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Hubei Guangji Pharmaceutical Co Ltd:

  • The EOD is 1.262. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.818. Based on the equity, the company is underpriced. +1
  • The TTM is 1.818. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.262MRQ1.818-0.555
MRQ1.818TTM1.8180.000
TTM1.818YOY1.910-0.092
TTM1.8185Y2.381-0.563
5Y2.38110Y4.868-2.487
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Hubei Guangji Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1150.1150%0.241-52%0.410-72%0.207-45%
Book Value Per Share--4.2144.2140%4.100+3%3.478+21%2.637+60%
Current Ratio--1.5371.5370%1.312+17%1.150+34%0.760+102%
Debt To Asset Ratio--0.3960.3960%0.292+36%0.386+2%0.495-20%
Debt To Equity Ratio--0.6500.6500%0.409+59%0.654-1%1.138-43%
Dividend Per Share--0.1140.1140%0.101+13%0.116-2%0.101+13%
Eps--0.1420.1420%0.311-54%0.279-49%0.216-34%
Free Cash Flow Per Share---0.448-0.4480%-0.058-87%0.012-3776%0.024-1991%
Free Cash Flow To Equity Per Share--0.4020.4020%-0.191+147%0.135+197%0.077+423%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.900+11%
Intrinsic Value_10Y_max---0.433--------
Intrinsic Value_10Y_min---6.452--------
Intrinsic Value_1Y_max--0.009--------
Intrinsic Value_1Y_min---0.277--------
Intrinsic Value_3Y_max---0.012--------
Intrinsic Value_3Y_min---1.157--------
Intrinsic Value_5Y_max---0.082--------
Intrinsic Value_5Y_min---2.387--------
Market Cap1882540477.440-44%2711440372.7402711440372.7400%2770731567.360-2%2773381629.108-2%3601566919.851-25%
Net Profit Margin--0.0630.0630%0.132-52%0.125-50%0.100-37%
Operating Margin--0.0640.0640%0.104-39%0.140-54%0.151-58%
Operating Ratio--1.5221.5220%1.502+1%1.389+10%1.250+22%
Pb Ratio1.262-44%1.8181.8180%1.910-5%2.381-24%4.868-63%
Pe Ratio37.389-44%53.83453.8340%25.164+114%32.760+64%143.726-63%
Price Per Share5.320-44%7.6607.6600%7.830-2%7.837-2%10.178-25%
Price To Free Cash Flow Ratio-11.872+31%-17.093-17.0930%-133.858+683%21.191-181%25.575-167%
Price To Total Gains Ratio23.312-44%33.56633.5660%22.943+46%20.980+60%183.049-82%
Quick Ratio--0.3090.3090%0.376-18%0.264+17%0.225+37%
Return On Assets--0.0200.0200%0.054-62%0.052-61%0.043-52%
Return On Equity--0.0340.0340%0.075-55%0.090-63%0.085-61%
Total Gains Per Share--0.2280.2280%0.341-33%0.527-57%0.307-26%
Usd Book Value--206018425.335206018425.3350%200356025.213+3%169961233.285+21%128879405.093+60%
Usd Book Value Change Per Share--0.0160.0160%0.033-52%0.057-72%0.029-45%
Usd Book Value Per Share--0.5820.5820%0.566+3%0.480+21%0.364+60%
Usd Dividend Per Share--0.0160.0160%0.014+13%0.016-2%0.014+13%
Usd Eps--0.0200.0200%0.043-54%0.039-49%0.030-34%
Usd Free Cash Flow---21906249.441-21906249.4410%-2858545.227-87%594293.744-3786%1041307.448-2204%
Usd Free Cash Flow Per Share---0.062-0.0620%-0.008-87%0.002-3776%0.003-1991%
Usd Free Cash Flow To Equity Per Share--0.0560.0560%-0.026+147%0.019+197%0.011+423%
Usd Market Cap259978839.934-44%374449915.475374449915.4750%382638029.452-2%383004002.980-2%497376391.631-25%
Usd Price Per Share0.735-44%1.0581.0580%1.081-2%1.082-2%1.406-25%
Usd Profit--6955578.1906955578.1900%15205800.710-54%13638552.304-49%10553421.463-34%
Usd Revenue--110154463.232110154463.2320%115604428.267-5%107665250.746+2%95906126.490+15%
Usd Total Gains Per Share--0.0320.0320%0.047-33%0.073-57%0.042-26%
 EOD+3 -5MRQTTM+0 -0YOY+11 -245Y+13 -2210Y+17 -19

3.2. Fundamental Score

Let's check the fundamental score of Hubei Guangji Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1537.389
Price to Book Ratio (EOD)Between0-11.262
Net Profit Margin (MRQ)Greater than00.063
Operating Margin (MRQ)Greater than00.064
Quick Ratio (MRQ)Greater than10.309
Current Ratio (MRQ)Greater than11.537
Debt to Asset Ratio (MRQ)Less than10.396
Debt to Equity Ratio (MRQ)Less than10.650
Return on Equity (MRQ)Greater than0.150.034
Return on Assets (MRQ)Greater than0.050.020
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Hubei Guangji Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.205
Ma 20Greater thanMa 505.644
Ma 50Greater thanMa 1005.550
Ma 100Greater thanMa 2006.668
OpenGreater thanClose5.120
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets2,469,054
Total Liabilities977,248
Total Stockholder Equity1,502,637
 As reported
Total Liabilities 977,248
Total Stockholder Equity+ 1,502,637
Total Assets = 2,469,054

Assets

Total Assets2,469,054
Total Current Assets1,005,495
Long-term Assets1,463,559
Total Current Assets
Cash And Cash Equivalents 431,353
Net Receivables 201,951
Inventory 221,471
Other Current Assets 50,444
Total Current Assets  (as reported)1,005,495
Total Current Assets  (calculated)905,219
+/- 100,276
Long-term Assets
Property Plant Equipment 1,199,183
Intangible Assets 150,616
Other Assets 69,628
Long-term Assets  (as reported)1,463,559
Long-term Assets  (calculated)1,419,427
+/- 44,131

Liabilities & Shareholders' Equity

Total Current Liabilities654,034
Long-term Liabilities323,214
Total Stockholder Equity1,502,637
Total Current Liabilities
Short Long Term Debt 197,126
Accounts payable 178,597
Other Current Liabilities 101,745
Total Current Liabilities  (as reported)654,034
Total Current Liabilities  (calculated)477,468
+/- 176,566
Long-term Liabilities
Long term Debt 244,950
Capital Lease Obligations Min Short Term Debt3,193
Other Liabilities 75,071
Long-term Liabilities Other 335
Deferred Long Term Liability 579
Long-term Liabilities  (as reported)323,214
Long-term Liabilities  (calculated)324,128
+/- 914
Total Stockholder Equity
Common Stock353,974
Retained Earnings 793,791
Total Stockholder Equity (as reported)1,502,637
Total Stockholder Equity (calculated)1,147,765
+/- 354,871
Other
Capital Stock353,974
Common Stock Shares Outstanding 353,974
Net Debt 10,722
Net Invested Capital 1,944,712
Net Tangible Assets 1,352,020
Net Working Capital 351,461
Property Plant and Equipment Gross 1,199,183



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
676,215
761,832
819,907
866,938
911,954
882,440
785,024
979,150
1,202,611
1,303,839
1,384,416
1,506,661
1,555,972
1,551,825
1,582,470
1,620,721
1,633,881
1,641,883
1,693,288
1,766,508
1,979,439
2,048,896
2,469,054
2,469,0542,048,8961,979,4391,766,5081,693,2881,641,8831,633,8811,620,7211,582,4701,551,8251,555,9721,506,6611,384,4161,303,8391,202,611979,150785,024882,440911,954866,938819,907761,832676,215
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
432,772
416,257
420,509
468,583
514,307
702,078
708,956
1,005,495
1,005,495708,956702,078514,307468,583420,509416,257432,772000000000000000
       Cash And Cash Equivalents 
92,103
95,484
135,765
58,055
35,659
22,110
62,110
172,205
220,124
188,813
211,753
152,305
125,013
111,039
194,782
161,929
116,737
140,835
173,552
183,653
350,306
293,332
431,353
431,353293,332350,306183,653173,552140,835116,737161,929194,782111,039125,013152,305211,753188,813220,124172,20562,11022,11035,65958,055135,76595,48492,103
       Short-term Investments 
25,000
0
0
11,000
10,000
10,000
10,500
0
0
0
0
42
0
0
0
0
0
0
0
0
0
0
0
0000000000042000010,50010,00010,00011,0000025,000
       Net Receivables 
127,766
164,478
157,497
224,664
212,215
220,792
125,983
140,608
85,068
114,452
90,028
76,675
84,447
136,954
63,685
132,180
159,331
153,462
165,476
126,135
104,126
203,333
201,951
201,951203,333104,126126,135165,476153,462159,331132,18063,685136,95484,44776,67590,028114,45285,068140,608125,983220,792212,215224,664157,497164,478127,766
       Other Current Assets 
41,234
49,987
46,313
40,515
69,015
53,556
39,443
62,527
126,093
84,243
57,394
48,256
24,414
31,992
67,985
39,789
30,959
27,862
31,068
52,813
27,167
47,465
50,444
50,44447,46527,16752,81331,06827,86230,95939,78967,98531,99224,41448,25657,39484,243126,09362,52739,44353,55669,01540,51546,31349,98741,234
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,217,624
1,221,375
1,224,705
1,252,201
1,277,361
1,339,941
1,463,559
1,463,5591,339,9411,277,3611,252,2011,224,7051,221,3751,217,6240000000000000000
       Property Plant Equipment 
218,775
256,611
277,543
325,425
352,544
370,966
354,641
414,389
572,787
737,740
832,145
931,729
1,047,240
1,036,392
854,646
942,543
974,429
969,342
959,492
963,400
1,041,909
1,069,179
1,199,183
1,199,1831,069,1791,041,909963,400959,492969,342974,429942,543854,6461,036,3921,047,240931,729832,145737,740572,787414,389354,641370,966352,544325,425277,543256,611218,775
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
38,947
35,480
34,029
31,617
0
0
0
0
000031,61734,02935,48038,947000000000000000
       Intangible Assets 
37,532
47,310
53,186
49,844
45,534
53,350
20,297
15,798
13,980
12,163
10,964
9,072
7,472
7,052
182,876
183,366
183,028
169,334
165,483
168,476
161,570
154,723
150,616
150,616154,723161,570168,476165,483169,334183,028183,366182,8767,0527,4729,07210,96412,16313,98015,79820,29753,35045,53449,84453,18647,31037,532
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
23,802
26,686
49,028
74,924
29,363
51,432
42,251
42,25151,43229,36374,92449,02826,68623,8020000000000000000
> Total Liabilities 
194,674
274,963
313,049
349,227
388,761
350,682
307,344
290,089
365,600
486,931
545,063
643,065
795,926
816,784
1,077,022
1,106,858
974,701
876,648
812,330
802,210
613,749
598,092
977,248
977,248598,092613,749802,210812,330876,648974,7011,106,8581,077,022816,784795,926643,065545,063486,931365,600290,089307,344350,682388,761349,227313,049274,963194,674
   > Total Current Liabilities 
125,570
234,859
262,946
275,687
304,641
271,553
229,844
280,089
348,757
328,779
404,553
520,474
637,122
689,326
693,891
561,026
794,977
762,707
727,994
701,607
460,428
540,286
654,034
654,034540,286460,428701,607727,994762,707794,977561,026693,891689,326637,122520,474404,553328,779348,757280,089229,844271,553304,641275,687262,946234,859125,570
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,000
145,000
479,537
466,700
482,013
0
0
0
000482,013466,700479,537145,00013,000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,000
145,000
479,537
466,700
482,013
203,637
236,279
197,126
197,126236,279203,637482,013466,700479,537145,00013,000000000000000000
       Accounts payable 
42,209
50,639
59,105
62,272
65,977
40,039
51,806
54,633
90,089
98,470
96,077
161,496
307,445
332,394
290,648
254,208
162,818
118,550
103,185
104,432
139,095
121,617
178,597
178,597121,617139,095104,432103,185118,550162,818254,208290,648332,394307,445161,49696,07798,47090,08954,63351,80640,03965,97762,27259,10550,63942,209
       Other Current Liabilities 
37,931
34,420
28,671
35,245
30,494
39,514
43,038
157,456
177,668
95,309
101,349
94,947
78,195
154,716
132,770
44,416
67,383
72,658
45,343
36,419
55,779
39,568
101,745
101,74539,56855,77936,41945,34372,65867,38344,416132,770154,71678,19594,947101,34995,309177,668157,45643,03839,51430,49435,24528,67134,42037,931
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
179,724
113,940
84,336
100,603
153,320
57,807
323,214
323,21457,807153,320100,60384,336113,940179,7240000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-13,000
-145,000
-479,537
-466,700
-482,013
0
1,649
3,193
3,1931,6490-482,013-466,700-479,537-145,000-13,000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,738
2,148
1,936
74,830
5,603
329
335
3353295,60374,8301,9362,14812,7380000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,055
6,478
5,873
5,865
1,243
116
0
579
57901161,2435,8655,8736,4789,055000000000000000
> Total Stockholder Equity
481,541
486,869
506,858
517,712
522,772
531,335
477,264
683,257
774,031
792,487
806,467
816,041
718,950
716,897
498,166
512,186
654,025
759,237
873,278
960,377
1,373,076
1,462,475
1,502,637
1,502,6371,462,4751,373,076960,377873,278759,237654,025512,186498,166716,897718,950816,041806,467792,487774,031683,257477,264531,335522,772517,712506,858486,869481,541
   Common Stock
171,226
171,226
171,226
171,226
171,226
171,226
251,706
251,706
251,706
251,706
251,706
251,706
251,706
251,706
251,706
251,706
251,706
251,706
251,706
251,706
346,995
344,000
353,974
353,974344,000346,995251,706251,706251,706251,706251,706251,706251,706251,706251,706251,706251,706251,706251,706251,706171,226171,226171,226171,226171,226171,226
   Retained Earnings 
84,312
87,557
104,444
113,670
117,971
125,250
139,349
322,824
386,355
401,654
412,333
414,821
319,257
321,679
178,765
199,687
341,526
446,737
590,779
677,870
675,117
764,584
793,791
793,791764,584675,117677,870590,779446,737341,526199,687178,765321,679319,257414,821412,333401,654386,355322,824139,349125,250117,971113,670104,44487,55784,312
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
23
-31
-25
-25-312380000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue783,856
Cost of Revenue-524,196
Gross Profit259,660259,660
 
Operating Income (+$)
Gross Profit259,660
Operating Expense-760,933
Operating Income22,923-501,273
 
Operating Expense (+$)
Research Development66,342
Selling General Administrative102,371
Selling And Marketing Expenses-
Operating Expense760,933168,712
 
Net Interest Income (+$)
Interest Income927
Interest Expense-38,832
Other Finance Cost-1,053
Net Interest Income-38,958
 
Pretax Income (+$)
Operating Income22,923
Net Interest Income-38,958
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-30,79822,923
EBIT - interestExpense = -38,832
-36,517
2,315
Interest Expense38,832
Earnings Before Interest and Taxes (EBIT)-8,034
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-30,798
Tax Provision-11,552
Net Income From Continuing Ops-42,351-42,351
Net Income-36,517
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-38,958
 

Technical Analysis of Hubei Guangji Pharmaceutical Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Hubei Guangji Pharmaceutical Co Ltd. The general trend of Hubei Guangji Pharmaceutical Co Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Hubei Guangji Pharmaceutical Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Hubei Guangji Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 5.6 < 6.17 < 6.18.

The bearish price targets are: 4.11.

Tweet this
Hubei Guangji Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Hubei Guangji Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Hubei Guangji Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Hubei Guangji Pharmaceutical Co Ltd. The current macd is -0.18420349.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Hubei Guangji Pharmaceutical Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Hubei Guangji Pharmaceutical Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Hubei Guangji Pharmaceutical Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Hubei Guangji Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartHubei Guangji Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Hubei Guangji Pharmaceutical Co Ltd. The current adx is 23.50.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Hubei Guangji Pharmaceutical Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Hubei Guangji Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Hubei Guangji Pharmaceutical Co Ltd. The current sar is 5.83696729.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Hubei Guangji Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Hubei Guangji Pharmaceutical Co Ltd. The current rsi is 43.20. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Hubei Guangji Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartHubei Guangji Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Hubei Guangji Pharmaceutical Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Hubei Guangji Pharmaceutical Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Hubei Guangji Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartHubei Guangji Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Hubei Guangji Pharmaceutical Co Ltd. The current cci is -85.0311262.

Hubei Guangji Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartHubei Guangji Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Hubei Guangji Pharmaceutical Co Ltd. The current cmo is -13.07302895.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Hubei Guangji Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartHubei Guangji Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Hubei Guangji Pharmaceutical Co Ltd. The current willr is -66.40625.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Hubei Guangji Pharmaceutical Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Hubei Guangji Pharmaceutical Co Ltd Daily Williams %R ChartHubei Guangji Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Hubei Guangji Pharmaceutical Co Ltd.

Hubei Guangji Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Hubei Guangji Pharmaceutical Co Ltd. The current atr is 0.25755795.

Hubei Guangji Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartHubei Guangji Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Hubei Guangji Pharmaceutical Co Ltd. The current obv is 136,036,743.

Hubei Guangji Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartHubei Guangji Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Hubei Guangji Pharmaceutical Co Ltd. The current mfi is 33.60.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Hubei Guangji Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartHubei Guangji Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Hubei Guangji Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-21BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Hubei Guangji Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Hubei Guangji Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.205
Ma 20Greater thanMa 505.644
Ma 50Greater thanMa 1005.550
Ma 100Greater thanMa 2006.668
OpenGreater thanClose5.120
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Hubei Guangji Pharmaceutical Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Hubei Guangji Pharmaceutical Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Hubei Guangji Pharmaceutical Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Hubei Guangji Pharmaceutical Co Ltd

I send you an email if I find something interesting about Hubei Guangji Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Hubei Guangji Pharmaceutical Co Ltd.

Receive notifications about Hubei Guangji Pharmaceutical Co Ltd in your mailbox!